Literature DB >> 3929211

Antibody-dependent cell cytotoxicity against Trypanosoma cruzi is only mediated by protective antibodies.

M V Lima-Martins, G A Sanchez, A U Krettli, Z Brener.   

Abstract

The antibody-dependent cell cytotoxicity (ADCC) to Trypanosoma cruzi blood forms (Btry) using non-adherent spleen cells is only mediated by sera from chronic chagasic patients or mice. Both display 'lytic antibodies' (LA), which are immunoglobulins directed against epitopes only present in living BTry, and 'conventional serology antibodies' (CSA), which are responsible for the positive diagnostic tests in Chagas disease. Sera from mice immunized with different T. cruzi antigens or from treated patients (displaying only CSA but not LA) are unable to mediate ADCC. These data confirm the central role played by LA in the host resistance against T. cruzi. Moreover, they probably explain why most immunizing agents used as vaccines in Chagas' disease and which elicit CSA but not LA, do not display significant protection against T. cruzi. We also demonstrate that trypsinization of BTry increases significantly the rate of parasite destruction by ADCC, suggesting that enzyme sensitive membrane components may help BTry to evade from this immune effector mechanism.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3929211     DOI: 10.1111/j.1365-3024.1985.tb00083.x

Source DB:  PubMed          Journal:  Parasite Immunol        ISSN: 0141-9838            Impact factor:   2.280


  10 in total

1.  B cells modulate T cells so as to favour T helper type 1 and CD8+ T-cell responses in the acute phase of Trypanosoma cruzi infection.

Authors:  Fabiola Cardillo; Edilberto Postol; Jorge Nihei; Luiz S Aroeira; Auro Nomizo; José Mengel
Journal:  Immunology       Date:  2007-07-16       Impact factor: 7.397

2.  Importance of the CCR5-CCL5 axis for mucosal Trypanosoma cruzi protection and B cell activation.

Authors:  Nicole L Sullivan; Christopher S Eickhoff; Xiuli Zhang; Olivia K Giddings; Thomas E Lane; Daniel F Hoft
Journal:  J Immunol       Date:  2011-06-29       Impact factor: 5.422

3.  Passive transfer of a monoclonal antibody specific for a sialic acid-dependent epitope on the surface of Trypanosoma cruzi trypomastigotes reduces infection in mice.

Authors:  G Franchin; V L Pereira-Chioccola; S Schenkman; M M Rodrigues
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 4.  Carbohydrate immunity in American trypanosomiasis.

Authors:  L R Travassos; I C Almeida
Journal:  Springer Semin Immunopathol       Date:  1993

5.  Deficiency of antigen-specific B cells results in decreased Trypanosoma cruzi systemic but not mucosal immunity due to CD8 T cell exhaustion.

Authors:  Nicole L Sullivan; Christopher S Eickhoff; John Sagartz; Daniel F Hoft
Journal:  J Immunol       Date:  2015-01-16       Impact factor: 5.422

6.  Involvement of CD4(+) Th1 cells in systemic immunity protective against primary and secondary challenges with Trypanosoma cruzi.

Authors:  D F Hoft; A R Schnapp; C S Eickhoff; S T Roodman
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.

Authors:  Anita R Schnapp; Chris S Eickhoff; Donata Sizemore; Roy Curtiss; Daniel F Hoft
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

8.  Recombinant antibody against Trypanosoma cruzi from patients with chronic Chagas heart disease recognizes mammalian nervous system.

Authors:  Leticia L Niborski; Mariana Potenza; Renato G S Chirivi; Leandro Simonetti; Micaela S Ossowski; Vanina Grippo; Maria May; Daniela I Staquicini; Adriana Parodi-Talice; Carlos Robello; Marcelo A Comini; Guillermo D Alonso; Jos M H Raats; Karina A Gómez
Journal:  EBioMedicine       Date:  2021-01-08       Impact factor: 8.143

9.  Comparison of the C-mediating killing activity and C-activating properties of mouse monoclonal and polyclonal antibodies against Trypanosoma cruzi.

Authors:  T L Kipnis; D V Tambourgi; M J Alves; W D Silva
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

Review 10.  Chagas' disease: an update on immune mechanisms and therapeutic strategies.

Authors:  Silvia Beatriz Boscardin; Ana Claudia Troccoli Torrecilhas; Romina Manarin; Silvia Revelli; Elena Gonzalez Rey; Renata Rosito Tonelli; Ariel Mariano Silber
Journal:  J Cell Mol Med       Date:  2010-01-11       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.